Clinical trial

DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term…

NCT00444353 · Bausch Health Americas, Inc., Industry · Completed

Key facts

NCT number NCT00444353
Title DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up
Official title A Randomized Study of the Safety and Effectiveness of DL6049 (Injectable Poly-l-lactic Acid) Versus Cosmoplast Collagen Implant in the Treatment of Nasolabial Fold Wrinkles (Long Term Follow-up)
Lead sponsor Bausch Health Americas, Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Nasolabial Fold Wrinkles
Intervention type Device
Interventions DL6049 (injectable poly-L-lactic acid)
Enrollment 240
Start date Aug 1, 2004
Completion Jan 1, 2007
First posted Mar 7, 2007
Last update posted Sep 18, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies